25 XP   0   0   10

MiMedx Group Inc
Buy, Hold or Sell?

Let's analyse Mimedx together

PenkeI guess you are interested in MiMedx Group Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MiMedx Group Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about MiMedx Group Inc

I send you an email if I find something interesting about MiMedx Group Inc.

Quick analysis of Mimedx (30 sec.)










What can you expect buying and holding a share of Mimedx? (30 sec.)

How much money do you get?

How much money do you get?
$0.03
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
$0.97
Expected worth in 1 year
$5.35
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$4.40
Return On Investment
70.2%

For what price can you sell your share?

Current Price per Share
$6.27
Expected price per share
$5.57 - $7.61
How sure are you?
50%

1. Valuation of Mimedx (5 min.)




Live pricePrice per Share (EOD)

$6.27

Intrinsic Value Per Share

$-0.23 - $7.38

Total Value Per Share

$0.74 - $8.35

2. Growth of Mimedx (5 min.)




Is Mimedx growing?

Current yearPrevious yearGrowGrow %
How rich?$142.7m-$17.9m$160.7m112.6%

How much money is Mimedx making?

Current yearPrevious yearGrowGrow %
Making money$67.4m-$30.1m$97.6m144.8%
Net Profit Margin21.0%-11.3%--

How much money comes from the company's main activities?

3. Financial Health of Mimedx (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#312 / 1010

Most Revenue
#111 / 1010

Most Profit
#80 / 1010

Most Efficient
#82 / 1010

What can you expect buying and holding a share of Mimedx? (5 min.)

Welcome investor! Mimedx's management wants to use your money to grow the business. In return you get a share of Mimedx.

What can you expect buying and holding a share of Mimedx?

First you should know what it really means to hold a share of Mimedx. And how you can make/lose money.

Speculation

The Price per Share of Mimedx is $6.27. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mimedx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mimedx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.97. Based on the TTM, the Book Value Change Per Share is $1.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mimedx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.467.3%0.467.3%-0.25-4.0%-0.12-1.9%-0.01-0.2%
Usd Book Value Change Per Share1.0917.4%1.0917.4%-0.12-2.0%0.132.0%0.050.8%
Usd Dividend Per Share0.010.1%0.010.1%0.000.1%0.142.2%0.071.1%
Usd Total Gains Per Share1.1017.5%1.1017.5%-0.12-1.9%0.274.3%0.121.9%
Usd Price Per Share8.77-8.77-2.78-6.85-7.84-
Price to Earnings Ratio19.11-19.11--11.11--27.57-353.98-
Price-to-Total Gains Ratio7.97-7.97--23.45-135.73-81.57-
Price to Book Ratio9.03-9.03--22.71-387.52-200.95-
Price-to-Total Gains Ratio7.97-7.97--23.45-135.73-81.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.27
Number of shares159
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.14
Usd Book Value Change Per Share1.090.13
Usd Total Gains Per Share1.100.27
Gains per Quarter (159 shares)174.9542.44
Gains per Year (159 shares)699.81169.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
146956908981160
2913911390178161330
31320862090268242500
41727822790357322670
52234773490446403840
626417341905354831010
730486848906255641180
835556455907146441350
939625962908037251520
1043695569908928061690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%5.05.00.050.0%5.013.00.027.8%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.02.01.040.0%5.04.01.050.0%11.05.02.061.1%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.01.080.0%4.00.06.040.0%4.00.014.022.2%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.01.01.060.0%6.03.01.060.0%12.04.02.066.7%

Fundamentals of Mimedx

About MiMedx Group Inc

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was incorporated in 2011 and is headquartered in Marietta, Georgia.

Fundamental data was last updated by Penke on 2024-04-11 14:24:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of MiMedx Group Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Mimedx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Mimedx to the Biotechnology industry mean.
  • A Net Profit Margin of 21.0% means that $0.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MiMedx Group Inc:

  • The MRQ is 21.0%. The company is making a huge profit. +2
  • The TTM is 21.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ21.0%TTM21.0%0.0%
TTM21.0%YOY-11.3%+32.3%
TTM21.0%5Y-4.5%+25.5%
5Y-4.5%10Y1.5%-6.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ21.0%-207.2%+228.2%
TTM21.0%-216.8%+237.8%
YOY-11.3%-282.3%+271.0%
5Y-4.5%-436.8%+432.3%
10Y1.5%-597.3%+598.8%
1.1.2. Return on Assets

Shows how efficient Mimedx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mimedx to the Biotechnology industry mean.
  • 28.2% Return on Assets means that Mimedx generated $0.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MiMedx Group Inc:

  • The MRQ is 28.2%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 28.2%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ28.2%TTM28.2%0.0%
TTM28.2%YOY-17.6%+45.8%
TTM28.2%5Y-8.7%+36.9%
5Y-8.7%10Y1.9%-10.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ28.2%-13.3%+41.5%
TTM28.2%-12.8%+41.0%
YOY-17.6%-11.6%-6.0%
5Y-8.7%-13.8%+5.1%
10Y1.9%-15.6%+17.5%
1.1.3. Return on Equity

Shows how efficient Mimedx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mimedx to the Biotechnology industry mean.
  • 47.3% Return on Equity means Mimedx generated $0.47 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MiMedx Group Inc:

  • The MRQ is 47.3%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 47.3%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ47.3%TTM47.3%0.0%
TTM47.3%YOY-+47.3%
TTM47.3%5Y-2,511.2%+2,558.4%
5Y-2,511.2%10Y-1,248.5%-1,262.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ47.3%-16.9%+64.2%
TTM47.3%-16.1%+63.4%
YOY--14.9%+14.9%
5Y-2,511.2%-19.3%-2,491.9%
10Y-1,248.5%-20.1%-1,228.4%

1.2. Operating Efficiency of MiMedx Group Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mimedx is operating .

  • Measures how much profit Mimedx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mimedx to the Biotechnology industry mean.
  • An Operating Margin of 11.5% means the company generated $0.12  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MiMedx Group Inc:

  • The MRQ is 11.5%. The company is operating less efficient.
  • The TTM is 11.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ11.5%TTM11.5%0.0%
TTM11.5%YOY-9.3%+20.9%
TTM11.5%5Y-3.7%+15.3%
5Y-3.7%10Y2.1%-5.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.5%-298.0%+309.5%
TTM11.5%-238.5%+250.0%
YOY-9.3%-288.4%+279.1%
5Y-3.7%-486.2%+482.5%
10Y2.1%-628.4%+630.5%
1.2.2. Operating Ratio

Measures how efficient Mimedx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.88 means that the operating costs are $0.88 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of MiMedx Group Inc:

  • The MRQ is 0.885. The company is less efficient in keeping operating costs low.
  • The TTM is 0.885. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.885TTM0.8850.000
TTM0.885YOY1.093-0.209
TTM0.8855Y1.037-0.153
5Y1.03710Y0.979+0.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8853.235-2.350
TTM0.8853.310-2.425
YOY1.0933.838-2.745
5Y1.0375.679-4.642
10Y0.9797.823-6.844

1.3. Liquidity of MiMedx Group Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mimedx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.57 means the company has $3.57 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of MiMedx Group Inc:

  • The MRQ is 3.570. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.570. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.570TTM3.5700.000
TTM3.570YOY3.081+0.489
TTM3.5705Y2.782+0.789
5Y2.78210Y2.675+0.106
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5703.863-0.293
TTM3.5704.169-0.599
YOY3.0815.337-2.256
5Y2.7826.122-3.340
10Y2.6756.434-3.759
1.3.2. Quick Ratio

Measures if Mimedx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mimedx to the Biotechnology industry mean.
  • A Quick Ratio of 2.95 means the company can pay off $2.95 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MiMedx Group Inc:

  • The MRQ is 2.953. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.953. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.953TTM2.9530.000
TTM2.953YOY2.519+0.434
TTM2.9535Y2.305+0.648
5Y2.30510Y2.268+0.037
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9533.504-0.551
TTM2.9533.991-1.038
YOY2.5195.371-2.852
5Y2.3056.088-3.783
10Y2.2686.395-4.127

1.4. Solvency of MiMedx Group Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mimedx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mimedx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.40 means that Mimedx assets are financed with 40.3% credit (debt) and the remaining percentage (100% - 40.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MiMedx Group Inc:

  • The MRQ is 0.403. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.403. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.403TTM0.4030.000
TTM0.403YOY1.105-0.702
TTM0.4035Y0.821-0.418
5Y0.82110Y0.579+0.242
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4030.339+0.064
TTM0.4030.337+0.066
YOY1.1050.271+0.834
5Y0.8210.368+0.453
10Y0.5790.388+0.191
1.4.2. Debt to Equity Ratio

Measures if Mimedx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mimedx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 67.5% means that company has $0.67 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MiMedx Group Inc:

  • The MRQ is 0.675. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.675. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.675TTM0.6750.000
TTM0.675YOY-+0.675
TTM0.6755Y458.593-457.918
5Y458.59310Y229.602+228.991
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6750.392+0.283
TTM0.6750.403+0.272
YOY-0.335-0.335
5Y458.5930.427+458.166
10Y229.6020.461+229.141

2. Market Valuation of MiMedx Group Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Mimedx generates.

  • Above 15 is considered overpriced but always compare Mimedx to the Biotechnology industry mean.
  • A PE ratio of 19.11 means the investor is paying $19.11 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MiMedx Group Inc:

  • The EOD is 13.663. Based on the earnings, the company is underpriced. +1
  • The MRQ is 19.111. Based on the earnings, the company is fair priced.
  • The TTM is 19.111. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD13.663MRQ19.111-5.448
MRQ19.111TTM19.1110.000
TTM19.111YOY-11.109+30.220
TTM19.1115Y-27.572+46.683
5Y-27.57210Y353.976-381.548
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD13.663-2.300+15.963
MRQ19.111-2.656+21.767
TTM19.111-2.718+21.829
YOY-11.109-4.145-6.964
5Y-27.572-6.258-21.314
10Y353.976-6.315+360.291
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MiMedx Group Inc:

  • The EOD is 37.426. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 52.349. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 52.349. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD37.426MRQ52.349-14.923
MRQ52.349TTM52.3490.000
TTM52.349YOY-19.854+72.203
TTM52.3495Y-23.827+76.176
5Y-23.82710Y23.050-46.878
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD37.426-2.974+40.400
MRQ52.349-3.306+55.655
TTM52.349-3.508+55.857
YOY-19.854-5.613-14.241
5Y-23.827-8.378-15.449
10Y23.050-8.873+31.923
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Mimedx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 9.03 means the investor is paying $9.03 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of MiMedx Group Inc:

  • The EOD is 6.456. Based on the equity, the company is overpriced. -1
  • The MRQ is 9.031. Based on the equity, the company is overpriced. -1
  • The TTM is 9.031. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.456MRQ9.031-2.574
MRQ9.031TTM9.0310.000
TTM9.031YOY-22.712+31.743
TTM9.0315Y387.521-378.491
5Y387.52110Y200.952+186.569
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.4561.914+4.542
MRQ9.0312.116+6.915
TTM9.0312.097+6.934
YOY-22.7122.881-25.593
5Y387.5213.550+383.971
10Y200.9523.936+197.016
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of MiMedx Group Inc.

3.1. Institutions holding MiMedx Group Inc

Institutions are holding 66.695% of the shares of MiMedx Group Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Essex Woodlands Health Ventures19.185961.191528195249281952490
2023-12-31BlackRock Inc6.48720.002195335185956246.664
2023-12-31Vanguard Group Inc4.46880.001365672541300992.0211
2023-12-31State Street Corporation2.78240.00174088962-40377-0.9778
2023-12-31Paradigm Capital Management, Inc.2.33431.56483430400-50000-1.4366
2023-12-31Geode Capital Management, LLC1.72710.002325381821098384.5232
2023-12-31Cannell Capital LLC1.68824.717624809692072079.113
2023-12-31Morgan Stanley - Brokerage Accounts1.08030.00121587593102600.6505
2023-12-31Richmond Brothers Inc0.955621.46931404352-76980-5.1967
2023-12-31Divisadero Street Capital Management, LP0.87932.560612921611112161617.8672
2023-12-31Renaissance Technologies Corp0.85180.017125178516870015.5759
2023-12-31Charles Schwab Investment Management Inc0.77180.00251134213577045.3603
2023-12-31Royal Bank of Canada0.73430.0022107909725373730.7426
2023-12-31Northern Trust Corp0.73260.0017107658658700.5482
2023-12-31Goldman Sachs Group Inc0.66040.0008970474557733135.1291
2023-12-31Prudential Financial Inc0.63820.0124937960192102.0909
2023-12-31Arrowstreet Capital Limited Partnership0.62780.008592259525403237.9967
2023-09-30Kanen Wealth Management LLC0.62775.03159225238761110.4934
2023-12-31Royce & Associates, LP0.58690.0699862494-5500-0.6336
2023-12-31Federated Hermes Inc0.54940.0176807373-35247-4.183
Total 48.3796.676571083740+31556931+44.4%

3.2. Funds holding MiMedx Group Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.28810.0018336258200
2024-03-28iShares Russell 2000 ETF1.92090.0332282292613620.0483
2024-03-28SPDR® S&P Biotech ETF1.63430.24492401710302801.2769
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.17660.01381729173-1774-0.1025
2024-01-31Fidelity Small Cap Index0.79440.03651167447186011.6191
2024-03-28iShares Russell 2000 Value ETF0.73920.06671086281-689-0.0634
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.47420.0136696848140002.0502
2024-02-29Fidelity Extended Market Index0.44960.0141660733120731.8612
2024-03-29Schwab US Small-Cap ETF™0.36940.024554284100
2023-12-31Royce Small-Cap Opportunity Invmt0.36640.3669538418-22782-4.0595
2024-03-31Paradigm Micro-Cap0.34022.333450000000
2023-12-31Timpani Small Cap Growth Equity0.32311.59494747994747990
2024-03-28Invesco Dorsey Wright SmallCap Momt ETF0.31560.308646376100
2024-01-31Calamos Timpani Small Cap Growth I0.31011.3834455788-19011-4.004
2024-02-29Vanguard Russell 2000 ETF0.28530.0359419203327568.4762
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.28320.032941614400
2023-12-31Xtrackers S&P Global Infra Swap ETF 1C0.27971.637541097500
2024-02-29Vanguard Health Care ETF0.27270.015740069279682.0289
2023-12-31Federated Hermes MDT SCG Institutional0.26750.7376393046-47881-10.8592
2023-12-31Federated Hermes MDT Small Cap Growth IS0.26750.7402393046-47881-10.8592
Total 13.1589.636119336413+451821+2.3%

3.3. Insider Transactions

Insiders are holding 3.9% of the shares of MiMedx Group Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-13William Frank Iv HulseSELL203817.95
2024-02-20Ricci S WhitlowSELL152718.01
2024-02-16Ricci S WhitlowSELL154938.07
2023-11-21Rice DougBUY50007.16
2023-05-15Robert Benjamin SteinSELL36076.15
2023-05-10Peter M CarlsonSELL59765.93
2023-05-10Robert Benjamin SteinSELL58695.93
2023-05-10William Frank Iv HulseSELL58705.93
2023-05-04Robert Benjamin SteinSELL517565.34
2023-05-02William Lawrence PhelanSELL52003.8
2023-04-25Peter M CarlsonSELL60943.74
2023-04-25Robert Benjamin SteinSELL59873.74
2023-04-25William Lawrence PhelanSELL16283.74
2023-04-11Peter M CarlsonSELL61003.31
2023-04-11Robert Benjamin SteinSELL59963.31
2023-04-11William Lawrence PhelanSELL16323.31

4. Summary

4.1. Key Performance Indicators

The key performance indicators of MiMedx Group Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.0941.0940%-0.123+111%0.127+763%0.047+2224%
Book Value Per Share--0.9710.9710%-0.122+113%0.237+309%0.427+127%
Current Ratio--3.5703.5700%3.081+16%2.782+28%2.675+33%
Debt To Asset Ratio--0.4030.4030%1.105-64%0.821-51%0.579-30%
Debt To Equity Ratio--0.6750.6750%-+100%458.593-100%229.602-100%
Dividend Per Share--0.0070.0070%0.004+53%0.140-95%0.070-90%
Eps--0.4590.4590%-0.250+155%-0.120+126%-0.012+103%
Free Cash Flow Per Share--0.1680.1680%-0.140+184%-0.024+114%0.075+123%
Free Cash Flow To Equity Per Share--0.1090.1090%-0.144+232%0.033+232%0.025+345%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7.380--------
Intrinsic Value_10Y_min---0.231--------
Intrinsic Value_1Y_max--0.219--------
Intrinsic Value_1Y_min---0.024--------
Intrinsic Value_3Y_max--1.054--------
Intrinsic Value_3Y_min---0.071--------
Intrinsic Value_5Y_max--2.368--------
Intrinsic Value_5Y_min---0.118--------
Market Cap921426660.000-40%1288821660.0001288821660.0000%408543240.000+215%1006662300.000+28%1152297678.000+12%
Net Profit Margin--0.2100.2100%-0.113+154%-0.045+121%0.015+1280%
Operating Margin--0.1150.1150%-0.093+181%-0.037+132%0.021+437%
Operating Ratio--0.8850.8850%1.093-19%1.037-15%0.979-10%
Pb Ratio6.456-40%9.0319.0310%-22.712+352%387.521-98%200.952-96%
Pe Ratio13.663-40%19.11119.1110%-11.109+158%-27.572+244%353.976-95%
Price Per Share6.270-40%8.7708.7700%2.780+215%6.850+28%7.841+12%
Price To Free Cash Flow Ratio37.426-40%52.34952.3490%-19.854+138%-23.827+146%23.050+127%
Price To Total Gains Ratio5.698-40%7.9707.9700%-23.454+394%135.733-94%81.566-90%
Quick Ratio--2.9532.9530%2.519+17%2.305+28%2.268+30%
Return On Assets--0.2820.2820%-0.176+162%-0.087+131%0.019+1396%
Return On Equity--0.4730.4730%-+100%-25.112+5414%-12.485+2742%
Total Gains Per Share--1.1001.1000%-0.119+111%0.267+312%0.117+839%
Usd Book Value--142717000.000142717000.0000%-17988000.000+113%34863200.000+309%62808500.000+127%
Usd Book Value Change Per Share--1.0941.0940%-0.123+111%0.127+763%0.047+2224%
Usd Book Value Per Share--0.9710.9710%-0.122+113%0.237+309%0.427+127%
Usd Dividend Per Share--0.0070.0070%0.004+53%0.140-95%0.070-90%
Usd Eps--0.4590.4590%-0.250+155%-0.120+126%-0.012+103%
Usd Free Cash Flow--24620000.00024620000.0000%-20577000.000+184%-3454200.000+114%11053500.000+123%
Usd Free Cash Flow Per Share--0.1680.1680%-0.140+184%-0.024+114%0.075+123%
Usd Free Cash Flow To Equity Per Share--0.1090.1090%-0.144+232%0.033+232%0.025+345%
Usd Market Cap921426660.000-40%1288821660.0001288821660.0000%408543240.000+215%1006662300.000+28%1152297678.000+12%
Usd Price Per Share6.270-40%8.7708.7700%2.780+215%6.850+28%7.841+12%
Usd Profit--67439000.00067439000.0000%-30197000.000+145%-10461200.000+116%3008200.000+2142%
Usd Revenue--321477000.000321477000.0000%267841000.000+20%291055600.000+10%268606200.000+20%
Usd Total Gains Per Share--1.1001.1000%-0.119+111%0.267+312%0.117+839%
 EOD+4 -4MRQTTM+0 -0YOY+30 -55Y+29 -610Y+30 -5

4.2. Fundamental Score

Let's check the fundamental score of MiMedx Group Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.663
Price to Book Ratio (EOD)Between0-16.456
Net Profit Margin (MRQ)Greater than00.210
Operating Margin (MRQ)Greater than00.115
Quick Ratio (MRQ)Greater than12.953
Current Ratio (MRQ)Greater than13.570
Debt to Asset Ratio (MRQ)Less than10.403
Debt to Equity Ratio (MRQ)Less than10.675
Return on Equity (MRQ)Greater than0.150.473
Return on Assets (MRQ)Greater than0.050.282
Total9/10 (90.0%)

4.3. Technical Score

Let's check the technical score of MiMedx Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.726
Ma 20Greater thanMa 506.603
Ma 50Greater thanMa 1007.477
Ma 100Greater thanMa 2007.847
OpenGreater thanClose6.250
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income before Tax  -3,397-58,146-61,54351,505-10,038-19,953-29,99160,62430,633
Net Income  -29,979-19,305-49,28438,999-10,285-19,912-30,19797,63667,439
EBIT  -3,924-40,447-44,37139,366-5,005-19,966-24,97162,06137,090
Operating Income  -3,924-40,447-44,37139,366-5,005-19,966-24,97162,08737,116
Net Income from Continuing Operations  -25,580-23,704-49,28438,999-10,285-19,912-30,19734,5344,337



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets239,047
Total Liabilities96,330
Total Stockholder Equity142,717
 As reported
Total Liabilities 96,330
Total Stockholder Equity+ 142,717
Total Assets = 239,047

Assets

Total Assets239,047
Total Current Assets164,261
Long-term Assets74,786
Total Current Assets
Cash And Cash Equivalents 82,000
Net Receivables 53,871
Inventory 21,021
Other Current Assets 1,745
Total Current Assets  (as reported)164,261
Total Current Assets  (calculated)158,637
+/- 5,624
Long-term Assets
Property Plant Equipment 9,106
Goodwill 19,441
Intangible Assets 5,257
Long-term Assets Other 205
Long-term Assets  (as reported)74,786
Long-term Assets  (calculated)34,009
+/- 40,777

Liabilities & Shareholders' Equity

Total Current Liabilities46,008
Long-term Liabilities50,322
Total Stockholder Equity142,717
Total Current Liabilities
Short-term Debt 1,548
Accounts payable 9,048
Other Current Liabilities 36,960
Total Current Liabilities  (as reported)46,008
Total Current Liabilities  (calculated)47,556
+/- 1,548
Long-term Liabilities
Long term Debt 48,099
Long-term Liabilities Other 2,223
Long-term Liabilities  (as reported)50,322
Long-term Liabilities  (calculated)50,322
+/-0
Total Stockholder Equity
Common Stock146
Retained Earnings -133,678
Other Stockholders Equity 276,249
Total Stockholder Equity (as reported)142,717
Total Stockholder Equity (calculated)142,717
+/-0
Other
Capital Stock146
Cash and Short Term Investments 82,000
Common Stock Shares Outstanding 145,962
Current Deferred Revenue-1,548
Liabilities and Stockholders Equity 239,047
Net Debt -33,901
Net Invested Capital 190,816
Net Working Capital 118,253
Property Plant and Equipment Gross 29,134
Short Long Term Debt Total 48,099



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
14
0
9,692
9,692
7,352
27,096
35,183
84,694
109,259
135,913
193,263
121,255
122,844
122,844
202,032
187,929
171,430
239,047
239,047171,430187,929202,032122,844122,844121,255193,263135,913109,25984,69435,18327,0967,3529,6929,692014
   > Total Current Assets 
14
0
2,806
2,806
1,706
6,882
18,089
65,389
85,677
96,310
126,538
48,747
74,049
74,049
160,617
148,523
134,198
164,261
164,261134,198148,523160,61774,04974,04948,747126,53896,31085,67765,38918,0896,8821,7062,8062,806014
       Cash And Cash Equivalents 
6
0
2,654
2,654
1,341
4,112
6,754
44,078
46,582
28,486
34,391
27,476
45,118
45,118
95,812
87,083
65,950
82,000
82,00065,95087,08395,81245,11845,11827,47634,39128,48646,58244,0786,7544,1121,3412,6542,65406
       Short-term Investments 
200
0
0
0
0
0
0
0
5,750
3,000
0
0
0
0
0
0
0
0
000000003,0005,7500000000200
       Net Receivables 
0
0
38
0
162
1,892
7,654
16,093
26,672
53,755
67,151
656
454
454
45,468
41,096
43,788
53,871
53,87143,78841,09645,46845445465667,15153,75526,67216,0937,6541,89216203800
       Inventory 
0
0
31
31
112
713
3,023
3,881
5,133
7,460
17,814
9,467
15,986
15,986
10,361
11,389
13,183
21,021
21,02113,18311,38910,36115,98615,9869,46717,8147,4605,1333,8813,023713112313100
   > Long-term Assets 
1,100
8,240
6,886
6,886
5,646
20,215
17,094
19,305
23,582
39,603
66,725
72,508
48,795
48,795
41,415
39,406
37,232
74,786
74,78637,23239,40641,41548,79548,79572,50866,72539,60323,58219,30517,09420,2155,6466,8866,8868,2401,100
       Property Plant Equipment 
0
1,452
1,050
1,050
757
869
1,072
4,086
5,447
9,475
13,786
14,091
17,424
17,424
15,060
13,861
11,256
9,106
9,10611,25613,86115,06017,42417,42414,09113,7869,4755,4474,0861,0728697571,0501,0501,4520
       Goodwill 
0
858
858
858
858
4,040
4,040
4,040
4,040
4,040
20,203
19,976
19,976
19,976
19,976
19,976
19,976
19,441
19,44119,97619,97619,97619,97619,97619,97620,2034,0404,0404,0404,0404,0408588588588580
       Long Term Investments 
0
0
0
0
0
0
0
0
3,250
0
0
0
0
0
0
0
0
0
0000000003,25000000000
       Intangible Assets 
1,000
5,783
4,597
4,597
3,929
15,090
11,912
11,179
10,845
10,763
23,268
10,033
9,608
9,608
6,004
5,383
5,852
5,257
5,2575,8525,3836,0049,6089,60810,03323,26810,76310,84511,17911,91215,0903,9294,5974,5975,7831,000
       Long-term Assets Other 
100
146
382
382
103
214
70
214
0
487
354
2,867
1,787
1,787
375
186
148
205
2051481863751,7871,7872,867354487021470214103382382146100
> Total Liabilities 
11
36
3,620
3,620
1,252
15,200
15,175
11,126
19,930
27,925
60,263
47,458
73,189
73,189
202,182
187,847
189,418
96,330
96,330189,418187,847202,18273,18973,18947,45860,26327,92519,93011,12615,17515,2001,2523,6203,6203611
   > Total Current Liabilities 
1
26
629
629
1,252
7,917
5,071
9,608
18,404
26,777
50,732
45,810
71,547
71,547
59,162
42,357
43,557
46,008
46,00843,55742,35759,16271,54771,54745,81050,73226,77718,4049,6085,0717,9171,252629629261
       Short-term Debt 
0
18
0
0
403
1,296
0
0
0
0
31
0
0
3,750
1,176
1,248
1,440
1,548
1,5481,4401,2481,1763,750003100001,29640300180
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
31
0
0
3,750
0
0
0
0
00003,75000310000000000
       Accounts payable 
500
6
0
0
0
3,909
1,252
2,491
3,661
6,633
11,436
8,454
14,864
14,864
8,765
7,385
8,847
9,048
9,0488,8477,3858,76514,86414,8648,45411,4366,6333,6612,4911,2523,9090006500
       Other Current Liabilities 
1
3
629
629
848
6,621
3,819
7,117
14,743
20,144
39,296
37,356
29,765
56,683
50,397
34,972
34,710
36,960
36,96034,71034,97250,39756,68329,76537,35639,29620,14414,7437,1173,8196,62184862962931
   > Long-term Liabilities 
10
10
2,991
2,991
403
7,282
10,105
1,518
1,526
1,148
9,531
1,648
1,642
1,642
143,020
145,490
145,861
50,322
50,322145,861145,490143,0201,6421,6421,6489,5311,1481,5261,51810,1057,2824032,9912,9911010
       Long term Debt Total 
0
0
0
0
0
2,745
4,012
0
0
0
0
0
0
61,906
0
0
0
0
000061,9060000004,0122,74500000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
91,568
92,494
0
0
0092,49491,56800000000000000
       Other Liabilities 
0
0
0
0
0
4,537
6,092
1,518
1,526
1,148
9,500
1,648
1,642
621
3,755
4,869
2,335
0
02,3354,8693,7556211,6421,6489,5001,1481,5261,5186,0924,53700000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
487
354
0
0
0
0
0
0
0
0000000354487000000000
> Total Stockholder Equity
3
-36
6,072
6,072
6,101
11,897
20,007
73,568
89,329
107,988
133,000
73,797
49,655
49,655
-150
82
-17,988
142,717
142,717-17,98882-15049,65549,65573,797133,000107,98889,32973,56820,00711,8976,1016,0726,072-363
   Common Stock
23
23
50
50
64
74
88
104
108
109
110
113
113
113
113
113
114
146
14611411311311311311311010910810488746450502323
   Retained Earnings -133,678-17,988-161,709-151,424-76,560-76,560-46,581-26,155-38,129-67,575-73,796-69,684-62,021-51,827-40,408-40,408-1,476-1,438
   Capital Surplus 
0
0
0
0
0
73,869
89,628
147,284
162,433
163,133
161,261
0
164,744
147,231
158,610
165,695
0
0
00165,695158,610147,231164,7440161,261163,133162,433147,28489,62873,86900000
   Treasury Stock00-4,017-7,449-10,806-38,6420-2,216-17,125-5,637-25-25-2500000
   Other Stockholders Equity 
1,418
1,418
46,429
46,429
57,864
75,644
91,882
149,561
160,295
150,987
167,550
132,943
0
144,689
151,161
161,678
-92,608
276,249
276,249-92,608161,678151,161144,6890132,943167,550150,987160,295149,56191,88275,64457,86446,42946,4291,4181,418



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue321,477
Cost of Revenue-54,634
Gross Profit266,843266,843
 
Operating Income (+$)
Gross Profit266,843
Operating Expense-229,727
Operating Income37,11637,116
 
Operating Expense (+$)
Research Development12,665
Selling General Administrative206,724
Selling And Marketing Expenses0
Operating Expense229,727219,389
 
Net Interest Income (+$)
Interest Income0
Interest Expense-6,457
Other Finance Cost-143
Net Interest Income-6,314
 
Pretax Income (+$)
Operating Income37,116
Net Interest Income-6,314
Other Non-Operating Income Expenses0
Income Before Tax (EBT)30,63337,142
EBIT - interestExpense = 30,633
30,633
73,896
Interest Expense6,457
Earnings Before Interest and Taxes (EBIT)37,09037,090
Earnings Before Interest and Taxes (EBITDA)40,517
 
After tax Income (+$)
Income Before Tax30,633
Tax Provision-597
Net Income From Continuing Ops4,33730,036
Net Income67,439
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses284,361
Total Other Income/Expenses Net-266,314
 

Technical Analysis of Mimedx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mimedx. The general trend of Mimedx is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mimedx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MiMedx Group Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.57 < 7.61 < 7.61.

The bearish price targets are: 5.59 > 5.59 > 5.57.

Tweet this
MiMedx Group Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MiMedx Group Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MiMedx Group Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MiMedx Group Inc. The current macd is -0.35545235.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mimedx price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Mimedx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Mimedx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MiMedx Group Inc Daily Moving Average Convergence/Divergence (MACD) ChartMiMedx Group Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MiMedx Group Inc. The current adx is 45.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Mimedx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
MiMedx Group Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MiMedx Group Inc. The current sar is 6.556502.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
MiMedx Group Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MiMedx Group Inc. The current rsi is 33.73. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
MiMedx Group Inc Daily Relative Strength Index (RSI) ChartMiMedx Group Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MiMedx Group Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mimedx price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
MiMedx Group Inc Daily Stochastic Oscillator ChartMiMedx Group Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MiMedx Group Inc. The current cci is -71.94824129.

MiMedx Group Inc Daily Commodity Channel Index (CCI) ChartMiMedx Group Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MiMedx Group Inc. The current cmo is -30.77986727.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
MiMedx Group Inc Daily Chande Momentum Oscillator (CMO) ChartMiMedx Group Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MiMedx Group Inc. The current willr is -54.74852179.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Mimedx is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
MiMedx Group Inc Daily Williams %R ChartMiMedx Group Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MiMedx Group Inc.

MiMedx Group Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MiMedx Group Inc. The current atr is 0.2716922.

MiMedx Group Inc Daily Average True Range (ATR) ChartMiMedx Group Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MiMedx Group Inc. The current obv is 12,789,713.

MiMedx Group Inc Daily On-Balance Volume (OBV) ChartMiMedx Group Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MiMedx Group Inc. The current mfi is 32.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
MiMedx Group Inc Daily Money Flow Index (MFI) ChartMiMedx Group Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MiMedx Group Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

MiMedx Group Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MiMedx Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.726
Ma 20Greater thanMa 506.603
Ma 50Greater thanMa 1007.477
Ma 100Greater thanMa 2007.847
OpenGreater thanClose6.250
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Mimedx with someone you think should read this too:
  • Are you bullish or bearish on Mimedx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mimedx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MiMedx Group Inc

I send you an email if I find something interesting about MiMedx Group Inc.


Comments

How you think about this?

Leave a comment

Stay informed about MiMedx Group Inc.

Receive notifications about MiMedx Group Inc in your mailbox!